WuXi STA, CFDA and Jinshan Government to co-host Marketing Authorization Holder regulatory summit in Shanghai
Industry and regulators combine to run afternoon congress on the implications of regulatory changes.
STA Pharmaceutical – a WuXi AppTec subsidiary – will co-host with the Shanghai Municipal Food and Drug Administration and the government of Jinshan District of Shanghai a special summit on the Marketing Authorization Holder (MAH) pilot program currently being implemented in 10 regions across China. The event will be held on June 22 June 2017 at the Jumeirah Himalayas Hotel in Shanghai.
The MAH has huge implications for international pharma and biotech companies, as it will expedite market access to the world’s second largest pharmaceutical economy by allowing license holders of a drug to sell in China using a contract manufacturer. Ultimately, this pilot will boost local innovation and enable a shorter time to market for drugs.
China's State Council has approved the pilot program in 10 provinces and municipalities: Beijing, Shanghai, Tianjin, Hebei, Guangdong, Jiangsu, Zhejiang, Fujian, Shandong, and Sichuan.
Yet despite this large opportunity, many foreign companies are yet to harness the growth potential and are unsure how to register or work with a local provider in the country. The symposium will provide a forum for the CFDA, US FDA, pharma/biotech companies, and CMOs to discuss latest policy updates, share their experiences and best practices.
Together, senior leaders from the CFDA and Jinshan government will explain in detail the process of registering an office in a pilot region, the execution of working with a local manufacturer, and post-market supervision. The Assistant Country Director from US FDA China Office will provide FDA perspectives on risk management as it relates to contract manufactures. Finally, a panel discussion including executives from multi-national pharma companies and domestic innovative drug development companies, CFDA and CDMO representatives will share case studies and answer questions from the audience.
Related News
-
News CPHI Frankfurt: Interview with Marcelo Cruz, Vice President, Business Development & Marketing at Tjoapack
In this series of interviews, we caught up with some of the exhibitors at CPHI Frankfurt to discover what innovations are being brought to the pharmaceutical industry this year. Here we chat with Marcelo Cruz of Tjoapack to discuss how global events ar... -
News CPHI Frankfurt 2022: Innovator Interviews – Bioiberica
In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We caught up with Mónica Gómez Navarro (Marketing Manager Branded Ingredients), ... -
News CPHI Frankfurt 2022: Innovator Interview – Procaps Group
In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We interviewed Rosella Del Vecchio Herrera, Marketing Director at Procaps Group, to discover h... -
News From the floor - CPHI Frankfurt 2022
The live blog from the people on the ground at CPHI Frankfurt - covering all stand-out news, memorable moments, and keynote updates from the 2022 event. -
News How to Commercialise an Advanced Therapy: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Andrea Zobel, Senior Director, Personalized Supply Chain at World Courier (Berlin Germany), Melissa Lattanzi, VP Emerging Therapies at AmerisourceBergen (King of Prussia, USA), and Hans-Peter Scherzer, Customer Suc... -
News CDMO - Health is a Joint Project: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Emanuele Agnese, Business Development Manager and Pietro Allegrini, R&D Director at Indena, present the ways in which a reliable manufacturing partner in the pursuit of better health outcomes for patients and pharm... -
News Streamlined Development for Efficient Production of Bispecific Molecules: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Séverine Fagète, VP, Cell Line Development Services at Selexis (Geneva, Switzerland), and Brandon Brino (Durham, USA), Process Development Scientist and Group Leader at KBI Biopharma, present an overv... -
News MDR – How to collect post-market clinical follow-up data (PMCF): Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Philipp Annecke, Junior Key Account Manager and Heinrich Martens, VP Regulatory Affairs of Fresenius Kabi (Bad Homburg, Germany) present guidances from the Medical Devices Regulation on clinical data evaluatio...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance